Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Academic radiology(2023)

引用 1|浏览22
暂无评分
摘要
•The prognosis of HCC patients with PVTT is poor, and PVTT is the factor limiting current treatment.•125I brachytherapy has a high LTCR in HCC patients with PVTT.•Patients aged <60 years, with type I+II PVTT, and with a tumor diameter <5 cm have a more favorable OS.•125I brachytherapy is safe for treating PVTT of HCC.
更多
查看译文
关键词
Hepatocellular carcinoma,Portal vein tumor thrombus,Iodine-125,local tumor control rate
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要